Patent Assignment
Reel/Frame 071526/0189
Change of Name
Recorded: 2025-06-26
Pages: 13
Assignor
SHENZHEN VYBIO PHAR MACEUTICAL TECHNOLO GY CO., LTD.
Executed: 2024-11-18
Assignee
ZHEJIANG YANGLI PHA RMACEUTICAL TECHNOL OGY CO., LTD.
ROOM 1106, BUILDING 1, HAOZHANG PLAZA, GONGSHU DISTRICT, HANGZHOU, ZHEJIANG, 310015, CHINA
Covered Properties
(3)
Isochroman Compound
Crystal Form of Isochroman Compound
Application:
18/843,719 →
Publication:
US 2025/0171474
Salt Form and Crystal Form of Tetrahydrocyclohepta Indazole Compound
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 14, 2023
From: CAI, ZHE; SUN, FEI; DING, CHARLES Z.; CHEN, SHUHUI
To: SHENZHEN VYBIO PHARMACEUTICAL TECHNOLOGY CO., LTD.
Reel/Frame 062969/0161 →
Assignment of Assignor's Interest
Sep 10, 2024
From: AN, KE; CHEN, SHUHUI
To: SHENZHEN VYBIO PHARMACEUTICAL TECHNOLOGY CO., LTD.
Reel/Frame 068533/0367 →
Assignment of Assignor's Interest
Oct 18, 2024
From: CAI, ZHE; SUN, FEI; DING,, CHARLES Z.
To: SHENZHEN VYBIO PHARMACEUTICAL TECHNOLOGY CO., LTD.
Reel/Frame 069207/0808 →
Change of Name
Jul 2, 2025
From: SHENZHEN VYBIO PHARMACEUTICAL TECHNOLOGY CO., LTD.
To: ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD.
Reel/Frame 071586/0563 →